Breast Cancer Methylomes Establish an Epigenomic Foundation for Metastasis
Fang Fang(Memorial Sloan Kettering Cancer Center), Timothy A. Chan(Cleveland Clinic), Adriana Heguy, Larry Norton(Memorial Sloan Kettering Cancer Center), Venkatraman Seshan(Memorial Sloan Kettering Cancer Center), Andrew Kaufman(Memorial Sloan Kettering Cancer Center), Andreas Rimner(University Medical Center Freiburg), Joan Massagué(Memorial Sloan Kettering Cancer Center), Linda T. Vahdat(Dartmouth–Hitchcock Medical Center), Stephen B. Baylin(Johns Hopkins University), Agnès Viale(Genomics (United Kingdom)), Qianxing Mo(Memorial Sloan Kettering Cancer Center), Luc G.T. Morris(Memorial Sloan Kettering Cancer Center), Ronglai Shen(Memorial Sloan Kettering Cancer Center), Dilip D. Giri(Memorial Sloan Kettering Cancer Center), Şevin Turcan(Memorial Sloan Kettering Cancer Center), Nita Ahuja(Johns Hopkins University), Mary Ellen Moynahan(Memorial Sloan Kettering Cancer Center)
Cited by 261
Related Papers
Comprehensive molecular characterization of gastric adenocarcinoma
|Nature|2014|6.5k
Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic
|Annals of Oncology|2018|2.9k
Smad transcription factors
|Genes & Development|2005|2.4k
Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals
|Cell|1994|2.1k
3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)
|Annals of Oncology|2016|2.1k